Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Cherepanov

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Nature Communications|November 14, 2023
Multiplexed detection of viral antigen and RNA using nanopore sensing and encoded molecular probesRen Ren, Shenglin Cai, Xiaona Fang, et al.
Research Square|June 9, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.
Vaccines|October 28, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 VaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.
Cell|July 8, 2023
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entryJim Baggen, Maarten Jacquemyn, Leentje Persoons, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Nature Communications|November 14, 2023
Multiplexed detection of viral antigen and RNA using nanopore sensing and encoded molecular probesRen Ren, Shenglin Cai, Xiaona Fang, et al.
Research Square|June 9, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.
Vaccines|October 28, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 VaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.
Cell|July 8, 2023
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entryJim Baggen, Maarten Jacquemyn, Leentje Persoons, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Pageof 13